Accord Healthcare
Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to more than 70 countries globally.
DRUG
REACTION
REPORT
GROWTH’S IN OUR NATURE
Accord Healthcare is one of the fastest growing generic pharmaceutical companies in Ireland and the UK.
Acquiring Actavis Ireland and the UK in 2017 facilitates Accord’s ambition of becoming a top 5 pan-EMEA generics company by 2020 and a leading player in the industry at European level.
TRULY MULTINATIONAL
Accord has one of the most extensive sales, marketing and distribution networks in Europe. Accord now supplies products in close to 65 EMENA markets.
A COMPLETE APPROACH
Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.
EUROPEAN FOCUS
Accord currently has a portfolio comprising nearly 7000 product approvals in Europe. We operate a pan European commercial footprint with direct presence in all major EU markets.
News
ACCORD HEALTHCARE LAUNCH ALENDRONIC ACID/CHOLECALCIFEROL
Accord Healthcare is delighted to announce the launch of Alendronic acid/Cholecalciferol Accord 70 mg/2,800 IU x 4 Tablets and Alendronic acid/Cholecalciferol Accord 70 mg/5,600 IU x 4 Tablets.
ACCORD HEALTHCARE LAUNCH DARUNAVIR
Accord Healthcare is delighted to announce the launch of Darunavir 800 mg x 30 Film-Coated Tablets.
